DG01933 | |
DG番号 | DG01933 |
分類 | DGroup |
名称 | CYP2C19 inhibitor TYPE Metabolism |
ステム | - |
構造式 | |
メンバー | D00355 Lansoprazole (JP18/USP/INN) D08903 Dexlansoprazole (INN/USAN) D11858 Omeprazole magnesium, amoxicillin and rifabutin D09394 Fidaxomicin (JAN/USAN) DG00156 Ticlopidine D08594 Ticlopidine (INN) D01028 Ticlopidine hydrochloride (JP18/USP) DG00371 Fluconazole D00322 Fluconazole (JP18/USP/INN) D01429 Fosfluconazole (JAN/INN) D01980 Luliconazole (JAN/USAN/INN) D02691 Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN) D04112 Etravirine (JAN/USAN/INN) D00533 Oxcarbazepine (JAN/USP/INN) DG00848 Eslicarbazepine D09215 Eslicarbazepine (USAN/INN) D09612 Eslicarbazepine acetate (USAN) D05928 Stiripentol (JAN/USAN/INN) D07299 Lacosamide (JAN/USAN/INN) DG00942 Fluoxetine D00326 Fluoxetine (USAN/INN) D00823 Fluoxetine hydrochloride (JAN/USP) DG00943 Citalopram D07704 Citalopram (USP/INN) D00822 Citalopram hydrobromide (USP) D07705 Citalopram hydrochloride DG00946 Fluvoxamine D07984 Fluvoxamine (INN) D00824 Fluvoxamine maleate (JP18/USP) D02561 Moclobemide (USAN/INN) D01832 Modafinil (JAN/USP/INN) DG01156 Methylthioninium chloride C00220 Methylene blue D02312 Methylene blue (USP) D10537 Methylthioninium chloride hydrate (JAN) |
上位グループ | Metabolizing enzyme inhibitor |
注釈1 | - |
注釈2 | - |